As the human and economic costs of COVID-19 continue to mount, reinsurers are working with government entities and healthcare executives on how to mitigate the impacts of the virus on the sector. The growing use of telemedicine and capacity constraints within healthcare systems could potentially dull utilization increases; however, the financial costs will still be significant. Additionally, the reinsurance market’s ability and desire to innovate has seen it emerge as a capable private partner for public sector risk at a time when governments worldwide are looking to transfer risks from public to private balance sheets.
The coronavirus is reshaping norms across society and the economy as different actors are adapting to these changes and uncertainties. The second installment of this podcast series focuses on national resilience, the rise of telehealth and the potential post-COVID-19 world.
Richard Smith-Bingham and Dan Kaniewski of the Marsh & McLennan Advantage discuss how countries might reconsider their approach to national resilience preparedness in light of COVID-19.
Mary Kay O’Neill, a Health & Benefits Partner at Mercer and Bruce Hamory, M.D. and Chief Medical Officer for Oliver Wyman’s Health & Life Practice, discuss how the public’s relationship with telehealth has changed, what still needs to happen to maximize its impact and whether the changes arising from this crisis are likely to last.
Mike Poulos, Managing Director of Marsh, and President of Marsh Risk Consulting shares his predictions for the long-term impacts of COVID-19.
Guy Carpenter is fortunate to be able to bring the power of Marsh & McLennan Companies to bear through this process by working closely with Marsh and Oliver Wyman to understand the impact of COVID-19 on governments, healthcare systems and the broader economy.